Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Viridian Therapeutics Inc (NASDAQ: VRDN) closed at $32.57 in the last session, down -0.09% from day before closing price of $32.6. In other words, the price has decreased by -$0.09 from its previous closing price. On the day, 0.85 million shares were traded. VRDN stock price reached its highest trading level at $33.29 during the session, while it also had its lowest trading level at $32.46.
Ratios:
We take a closer look at VRDN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 11.28 and its Current Ratio is at 11.28. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In the most recent recommendation for this company, Wedbush on December 10, 2025, Reiterated its Outperform rating but revised its target price to $47 from $42 previously.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 23 ’25 when Fairmount Funds Management LLC bought 454,545 shares for $22.00 per share. The transaction valued at 9,999,990 led to the insider holds 3,914,458 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRDN now has a Market Capitalization of 3108546048 and an Enterprise Value of 2830732288. For the stock, the TTM Price-to-Sale (P/S) ratio is 43.91 while its Price-to-Book (P/B) ratio in mrq is 8.53. Its current Enterprise Value per Revenue stands at 39.988 whereas that against EBITDA is -8.733.
Stock Price History:
The Beta on a monthly basis for VRDN is 0.94, which has changed by 0.8246498 over the last 52 weeks, in comparison to a change of 0.14045572 over the same period for the S&P500. Over the past 52 weeks, VRDN has reached a high of $33.34, while it has fallen to a 52-week low of $9.90. The 50-Day Moving Average of the stock is 23.58%, while the 200-Day Moving Average is calculated to be 76.69%.
Shares Statistics:
According to the various share statistics, VRDN traded on average about 1.40M shares per day over the past 3-months and 1271300 shares per day over the past 10 days. A total of 95.44M shares are outstanding, with a floating share count of 85.96M. Insiders hold about 9.93% of the company’s shares, while institutions hold 89.96% stake in the company. Shares short for VRDN as of 1764288000 were 9174113 with a Short Ratio of 6.56, compared to 1761868800 on 9762681. Therefore, it implies a Short% of Shares Outstanding of 9174113 and a Short% of Float of 9.98.
Earnings Estimates
The firm’s stock currently is rated by 10.0 analysts. The consensus estimate for the next quarter is -$1.13, with high estimates of -$1.02 and low estimates of -$1.26.
Analysts are recommending an EPS of between -$2.88 and -$4.74 for the fiscal current year, implying an average EPS of -$3.51. EPS for the following year is -$3.51, with 11.0 analysts recommending between -$2.33 and -$4.73.
Revenue Estimates
A total of 13 analysts have provided revenue estimates for VRDN’s current fiscal year. The highest revenue estimate was $125.79M, while the lowest revenue estimate was $70.7M, resulting in an average revenue estimate of $87.69M. In the same quarter a year ago, actual revenue was $302kBased on 14 analysts’ estimates, the company’s revenue will be $91.61M in the next fiscal year. The high estimate is $215.97M and the low estimate is $15.09M.
